FindTrial
Sign In

Application of Mini-Midline Catheters versus Midline Catheters for Short-term Infusion Therapy in Patients with Difficult Intravenous Access: A Randomized Clinical Trial

Application of Mini-Midline Catheters versus Midline Catheters for Short-term Infusion Therapy in Patients with Difficult Intravenous Access: A Randomized Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072298
Enrollment
Unknown
Registered
2023-06-09
Start date
2023-06-01
Completion date
Unknown
Last updated
2023-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Difficult intravenous access

Interventions

Experimental group:Placement of Mini-midline
Control group:Placement of Midline catheter

Sponsors

Sir Run Run Shaw Hospital Affiliated to Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Age 18 to 65 years; (2) Expected duration of infusion therapy is 1-4 weeks; (3) Infusion of drugs that meet the indications of Mini-midline and Midline catheter; (4) Difficult intravenous access due to obesity; (5) Clear consciousness and ability to communicate normally.

Exclusion criteria

Exclusion criteria: (1) A history of radiation therapy, thrombosis, or trauma at the catheterization site; (2) A planned discharge with the catheter; (3) Indications for central vascular access devices insertion.

Design outcomes

Primary

MeasureTime frame
The incidence of catheter-related complications;—

Secondary

MeasureTime frame
The unplanned extubation rate due to complications;Catheter dwell time;—

Countries

China

Contacts

Public ContactLinfang Zhao

Sir Run Run Shaw Hospital Affiliated to Zhejiang University School of Medicine

3193159@zju.edu.cn+86 135 8881 9123

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026